The DOI matches its Crossref record.
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Catecholamine levels are further increased by glucocorticoids, which block the transporters on glia that normally remove catecholamines from the extracellular space51.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 15
- Mark, A. J. Hypertension 14, 159–165 (1996).
- Schulteis, G. & Koob, G. Nature 371, 108–109 (1994). · DOI
- Brunner, H., Nelen, M., Breakefield, O., Ropers, H. & vanOost, B. Science 262, 578–580 (1993). · DOI · Paper page
- Pacholczyk, T., Blakely, R. & Amara, S. Nature 350, 350– 354 (1991). · DOI · Paper page
- Borowski, B. & Hoffman, B. Int. Rev. Neurobiol. 38, 139–199 (1995). · DOI
- Iversen, L. Br. J. Pharmacol. 25, 18–33 (1965).
- Trendelenburg, U. Handbook of Experimental Pharmacology Vol. 90 (eds Trendelenburg, U. & Weiner, N.) 279–319 (Springer, New York, 1988).
- Russ, H., Staudt, K., Martel, F., Gliese, M. & Schömig, E. Eur. J. Neurosci. 8, 1256– 1264 (1996). · DOI
- Karhunen, T., Tilgmann, C., Ulmanen, I., Julkunen, I. & Panula, P. J. Histochem. Cytochem. 42, 1079–1090 (1994). · DOI
- Eisenhofer, G., McCarty, R., Pacak, K., Russ, H. & Schömig, E. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 , 287–294 (1996). · DOI
- Gründemann, D. et al. J. Biol. Chem. 272, 10408– 10413 (1997). · DOI
- Schömig, E. et al. FEBS Lett. 425, 79– 86 (1998). · DOI
- Schömig, E. & Schönfeld, C.-L. Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 404–410 (1990). · DOI
- Iversen, L. Brit. J. Pharmacol. 24, 387–394 (1965).
- Luo, D.-F. et al. Am. J. Hum. Genet. 57, 911– 919 (1995).
Cited by
Sorted by citations
Items 201–300 of 350
Oxybutynin and trospium are substrates of the human organic cation transporters
Wenge, B., Geyer, J., & Bönisch, H. (2011) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-010-0590-x · Cited by 25
“The transporter responsible for extraneuronal monoamine uptake has later been identified by Schömig and coworkers (Gründemann et al. 1998) as ‘extraneuronal monoamine transporter’ (EMT or OCT3), i.”
BackgroundNoradrenergic–glucocorticoid mechanisms in emotion-induced amnesia: from adaptation to disease
Hurlemann, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1002-x · Cited by 26
Are organic cation transporters capable of transporting prostaglandins?
Harlfinger, S., Fork, C., Lazar, A., Schömig, E., & Gründemann, D. (2005) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-005-0011-8 · Cited by 25
“Since OCT1 and OCT2 also transport e.g. noradrenaline and adrenaline (Breidert et al. 1998; Gründemann et al. 1998a,b), all three carriers may contribute to inactivation of released monoamine transmitters in vivo.”
BackgroundSelf-citationModulation of MPP+ uptake by tea and some of its components in Caco-2 cells
Monteiro, R., Calhau, C., Martel, F., Faria, A., Mateus, N., & Azevedo, I. (2005) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-005-0012-7 · Cited by 25
“Caco-2 cells express at least two distinct Na+-independent transporters that may be responsible for MPP+ uptake: the organic cation transporter 1 (OCT1; SLC22A1; Martel et al. 2001) and the extraneuronal monoamine transporter, also known as OCT3 (SLC22A3; Gründemann et al. 1998; Kekuda et al. 1998), both belonging to…”
BackgroundAgmatine and putrescine uptake in the human glioma cell line SK-MG-1
Molderings, G., Bönisch, H., Göthert, M., & Brüss, M. (2001) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100100418 · Cited by 25
Activation of muscarinic receptors by non-neuronal acetylcholine.
Wessler, I., & Kirkpatrick, C. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-23274-9_20 · Cited by 25
Organic Cation Transporters in Brain Catecholamine Homeostasis
Gasser, P. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_470 · Cited by 28
Correa, A. H., Choi, M., Gironacci, M., Valera, M.-S., & Fernández, B. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.08.001 · Cited by 24
Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics
Sato, T., Kitayama, S., Mitsuhata, C., Ikeda, T., Morita, K., & Dohi, T. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002109900184 · Cited by 24
“There are also extraneuronal monoamine transporters in glial cells that contribute to the clearance of released monoamines (Gründemann et al. 1998).”
BackgroundNorepinephrine activates β1-adrenergic receptors at the inner nuclear membrane in astrocytes
Benton, K. C., Wheeler, D. S., Kurtoglu, B., Ansari, M. B., Cibich, D. P., Gonzalez, D. A., Herbst, M., Khursheed, S., Knorr, R. C., Lobner, D., et al. (2022) · Glia · doi:10.1002/glia.24219 · Cited by 23
Chaves, C., Campanelli, F., Chapy, H., Gomez-Zepeda, D., Glacial, F., Smirnova, M., Taghi, M., Pallud, J., Perrière, N., Declèves, X., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040308 · Cited by 23
Dopamine effects on stress-induced working memory deficits
Bahari, Z., Meftahi, G. H., & Meftahi, M. A. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000429 · Cited by 29
Intestinal uptake of MPP+ is differently affected by red and white wine.
Monteiro, R., Calhau, C., Martel, F., de Pinho, P. G., & Azevedo, I. (2005) · Life Science · doi:10.1016/j.lfs.2004.12.008 · Cited by 23
Wang, Y., Zhang, J., Li, Y., Qi, S., Zhang, F., Ball, L. J., & Duan, H. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad301 · Cited by 25
Amphoux, A., Millan, M., Cordi, A., Bönisch, H., Vialou, V., la Cour, C. M., Dupuis, D., Giros, B., & Gautron, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.012 · Cited by 22
Mooney, J., Samson, J. A., Hennen, J., Pappalardo, K. M., McHale, N., Alpert, J., Koutsos, M., & Schildkraut, J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.009 · Cited by 22
“…in the periphery (e.g., vascular and nonvascular smooth muscle; Martel & Azevedo, 2003) by a transmembrane protein (SL22A3) known as the extraneuronal monoamine transporter, the organic cation transporter type 3, or Uptake 2 (Burgen & Iversen, 1965; Gründemann et al., 1998; Wu et al., 1998).”
BackgroundRahman, Z., Ring, R., Young, K., Platt, B. J., Lin, Q., Schechter, L., Rosenzweig-Lipson, S., & Beyer, C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.062 · Cited by 22
Mendes, E. S., Horváth, G., Campos, M., & Wanner, A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.038 · Cited by 20
NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS
Kang, H.-J., Lee, S., Lee, C., Shim, J., Shin, H. J., Liu, K.-H., Yoo, M., & Shin, J.-G. (2006) · Drug Metabolism And Disposition · doi:10.1124/dmd.105.009126 · Cited by 22
“, 2000), cimetidine (Zhang et al., 1997; Grundemann et al., 1998), phenoxybenzamine, and corticosterone (Hayer-Zillgen et al.”
BackgroundInfluentialNies, A., Schaeffeler, E., & Schwab, M. (2022) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2022.108268 · Cited by 21
Brain Plasma Membrane Monoamine Transporter in Health and Disease
Vieira, L. S., & Wang, J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_446 · Cited by 23
Histamine Clearance Through Polyspecific Transporters in the Brain.
Yoshikawa, T., & Yanai, K. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_13 · Cited by 21
Wieland, A., Hayer-Zillgen, M., Bönisch, H., & Brüss, M. (2000) · Journal of neural transmission · doi:10.1007/s007020070028 · Cited by 21
“Beside the neuronal NAT, also the EMT contributes to the removal by the liver and kidney of circulating catecholamines (Graefe et al., 1998).”
BackgroundInfluentialOrganic Cation Transporter Expression and Function in the CNS
Sweet, D. H. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_463 · Cited by 25
Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette, J., Raghavan, N. G., Harris-McAllister, V., Preston, M. E., Webb, K., & O'Donnell, D. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.021 · Cited by 20
“inhibition of extraneuronal catecholamine transporter which may result in enhanced availability and action of norepinephrine with consequent greater bronchodilation.(41) Other non-genomic actions of ICS which have been shown in asthma are enhancement of norepinephrine-induced bronchial vasoconstriction which may act t…”
BackgroundIwai, M., Minematsu, T., Narikawa, S., Usui, T., & Kamimura, H. (2009) · Drug Metabolism And Disposition · doi:10.1124/dmd.109.027359 · Cited by 20
“OCT3 and OATP1A2 mRNA have also been detected in the liver (Kullak-Ublick et al., 1995; Gründemann et al., 1998).”
BackgroundLoss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis
Vollmar, J., Lautem, A., Closs, E., Schuppan, D., Kim, Y. O., Grimm, D., Marquardt, J., Fuchs, P., Straub, B., Schad, A., et al. (2017) · OncoTarget · doi:10.18632/oncotarget.23372 · Cited by 19
Self-citationYara, M., Iwao, B., Hara, N., Yamanaka, T., Uchino, H., & Inazu, M. (2015) · Placenta · doi:10.1016/j.placenta.2015.03.010 · Cited by 19
Li, H., Scholl, J. L., Tu, W., Hassell, J. E., Watt, M. J., Forster, G. L., & Renner, K. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12735 · Cited by 19
“This effect is not mediated by the serotonin transporter, but instead by OCT3, a corticosterone-sensitive monoamine transporter (Grudemann et al., 1998) that is widely distributed in the brain (Gasser et al.”
BackgroundSLC22 transporter family proteins as targets for cytostatic uptake into tumor cells
Gupta, S., Burckhardt, G., & Hagos, Y. (2011) · Biological chemistry · doi:10.1515/bc.2011.014 · Cited by 19
Monoamine transporters in human endometrium and decidua
Hansson, S. R., Bottalico, B., Noskova, V., & Casslén, B. G. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn048 · Cited by 24
“RNA probes of 400–560 nucleotides were used for the human SERT, NET, DAT, VMAT1, VMAT2, OCT1, OCT2, EMT, PMAT mRNAs (Pacholczyk et al., 1991; Erickson and Eiden, 1993; Ramamoorthy et al., 1993a; Uhl and Kitayama, 1993; Erickson et al., 1996; Gorboulev et al., 1997; Koehler et al., 1997; Zhang et al., 1997; Grundemann…”
BackgroundMethodMartel, F., & Keating, E. (2003) · Placenta · doi:10.1053/plac.2002.0917 · Cited by 19
Furihata, T., & Anzai, N. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00076 · Cited by 18
Verberne, H., de Bruin, K. D., Habraken, J., Somsen, G., Eersels, J., Moet, F., Booij, J., & van Eck-Smit, B. V. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0022-1 · Cited by 18
“heart, liver, skeletal muscle, placenta and kidney) [29, 30].”
Bönisch, H. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_516 · Cited by 21
NMDAR Neurotransmission Needed for Persistent Neuronal Firing: Potential Roles in Mental Disorders
Yang, S., Seo, H., Wang, M., & Arnsten, A. F. T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.654322 · Cited by 17
“High levels of glucocorticoids, released due to hypothalamic-pituitary-adrenal (HPA) actions, can also impair PFC working memory function (79), and may do so in part by blocking the extraneuronal catecholamine transporters on glia, which normally serve to reduce catecholamine levels in the extracellular space (80).”
BackgroundLi, R., Yang, C., Kwan, Y.-W., Chan, S.-W., Lee, S., & Leung, G. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00014 · Cited by 17
“OCT-3 (also called “extraneuronal monoamine transporter”) has a broad distribution and is found in the liver, heart, placenta, skeletal muscle, kidney, and brain (Gründemann et al., 1998; Wu et al., 2000).”
BackgroundRenal Organic Cation and Anion Transport: From Physiology to Genes
Sweet, D. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00802-2 · Cited by 19
Organic Cation Transporters in Psychiatric Disorders
Daws, L. C. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_473 · Cited by 17
Wang, Y., Moussian, B., Schaeffeler, E., Schwab, M. G., & Nies, A. T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.06.002 · Cited by 17
Molecular and kinetic characterization of histamine transport into adult rat cultured astrocytes.
Perdan-Pirkmajer, K., Pirkmajer, S., Černe, K., & Krz̄an, M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.002 · Cited by 16
“Choline is a substrate for rat OCT1 and OCT2 with Km and Vmax values comparable to histamine (Arndt et al., 2001), although it was previously thought that OCT2 does not mediate choline uptake (Grundemann et al., 1998).”
BackgroundWenge, B., & Bönisch, H. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0459-z · Cited by 16
“In the periphery and less pronounced also in the central nervous system, these monoamines are also taken up in nonneuronal (extraneuronal) tissues by means of Na+- and Cl−-independent, extraneuronal monoamine transporters (EMT; Gründemann et al. 1998; Schömig et al. 2006).”
BackgroundAgmatine signaling: odds and threads.
Berkels, R., Taubert, D., Gründemann, D., & Schömig, E. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2004.tb00128.x · Cited by 16
Self-citationPharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes
Berry, M. D., Hart, S., Pryor, A., Hunter, S., & Gardiner, D. (2016) · Scientific Reports · doi:10.1038/srep38006 · Cited by 15
“Corticosterone, a selective inhibitor of OCT3 36,51 , was also without effect (Fig.”
InfluentialHirata, T., Kumada, T., Kawasaki, T., Furukawa, T., Aiba, A., Conquet, F., Saga, Y., & Fukuda, A. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22030 · Cited by 14
“The components of the extra- neuronal uptake-2 system were recently identified as organic cation transporter 3 and plasma membrane monoamine transporter (Grundemann et al., 1998; Engel et al., 2004; Amphoux et al., 2006).”
BackgroundIntestinal oxidative state can alter nutrient and drug bioavailability
Ana, F., Monteiro, R., Pestana, D., de Freitas, V. D., Mateus, N., Azevedo, I., & Calhau, C. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9769 · Cited by 15
Lorenc-Koci, E., Antkiewicz-Michaluk, L., Wardas, J., Zapała, M., & Wierońska, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.044 · Cited by 15
Genetic and Epigenetic Regulation of Organic Cation Transporters.
Kölz, C., Schaeffeler, E., Schwab, M., & Nies, A. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_450 · Cited by 14
Budesonide reduces hospital admission rates in preschool children with acute wheezing
Razi, C. H., Çörüt, N., & Andıran, N. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23667 · Cited by 14
“These findings are originated from series of in vivo studies conducted on asthmatic or non-asthmatic subjects and from in vivo studies using airway vascular smooth muscle obtained from donor lungs.(29,30) The inhalation of 880mcg of Fluticasone propionate (FP) produces a decrease in airway blood flow between 30 and 60…”
BackgroundKoch, W., Mueller, J. C., Schrempf, M., Wolferstetter, H., Kirchhofer, J., Schömig, A., & Kastrati, A. (2013) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00739.x · Cited by 14
“SLC22A3 encodes solute carrier family 22 (extraneuronal monoamine transporter) member 3, a polyspecific organic cation transporter, and LPAL2 [Lp(a)-like 2] is a truncated version of LPA (Byrne et al., 1995; Gründemann et al., 1998; Gründemann & Schömig, 2000).”
BackgroundBreining, P., Pedersen, S. B., Pikelis, A., Rolighed, L., Sundelin, E. I. O., Jessen, N., & Richelsen, B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.024 · Cited by 12
Caki-1 Cells as a Model System for the Interaction of Renally Secreted Drugs with OCT3
Glube, N. D., & Langguth, P. (2008) · Nephron Physiology · doi:10.1159/000115040 · Cited by 13
Cova, E., Laforenza, U., Gastaldi, G., Sambuy, Y., Tritto, S., Faelli, A., & Ventura, U. (2002) · Journal of NutriLife · doi:10.1093/jn/132.7.1995 · Cited by 13
Noskova, V., Bottalico, B., Olsson, H., Ehinger, A., Pilka, R., Casslén, B., & Hansson, S. (2006) · Molecular human reproduction · doi:10.1093/molehr/gah259 · Cited by 12
“uptake in the proliferative phase may explain the difference since its sensitivity to corticosterone is 100-fold less compared to that of EMT (Grundemann et al., 1998; Hayer-Zillgen et al., 2002).”
BackgroundMethodResultInfluentialMolecular Targets for Steroids in Airway Vascular Smooth Muscle
Horvath, G., & Wanner, A. (2003) · Archives of Physiology and Biochemistry · doi:10.3109/13813450312331337559 · Cited by 12
“For RT-PCR amplification, primers were designed based on the published sequences of neuronal norepinephrine transporter (NET), organic cation transporter (OCT) 1 and 2, extraneuronal monoamine transporter (EMT) (Grundemann et al., 1998), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs.”
MethodHorvath, G., Torbati, A., Conner, G., Salathe, M., & Wanner, A. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0030oc · Cited by 12
Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine.
Pan, X., Wang, L., Gründemann, D., & Sweet, D. (2014) · Fitoterapia · doi:10.1016/j.fitote.2013.11.009 · Cited by 12
“The derivation of the human embryonic kidney 293 (HEK) cells stably transfected with hOCT1 (HEK-hOCT1), hOCT2 (HEK-hOCT2), hOCT3 (HEK-hOCT3), or the corresponding empty vector (background control), has been described previously [19,20].”
BackgroundSelf-citationCarboxylate-Capped Analogues of Ru265 are MCU Inhibitor Prodrugs
Bigham, N. P., Huang, Z., Spivey, J. A., Woods, J. J., MacMillan, S. N., & Wilson, J. J. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c02930 · Cited by 11
Mendes, E., Cadet, L., Arana, J., & Wanner, A. (2015) · Chest · doi:10.1378/chest.14-1742 · Cited by 11
Osredkar, D., Burnik-Papler, T., Pečavar, B., Kralj-Iglič, V., & Krz̄an, M. (2009) · Inflammation Research · doi:10.1007/s00011-009-8103-4 · Cited by 11
Kim, M. K., Han, L., Choi, M. K., Han, Y., Kim, D., Chung, S., & Shim, C. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20456 · Cited by 11
Transport of [3H]MPP+ in an immortalized rat brain microvessel endothelial cell line (RBE 4)
Martel, F., Calhau, C., Soares-da-Silva, P., & Azevedo, I. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000302 · Cited by 11
Clauss, N. J., Mayer, F. P., Owens, W. A., Vitela, M., Clarke, K. M., Bowman, M. A., Horton, R., Gründemann, D., Schmid, D., Holy, M., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02064-5 · Cited by 12
“To directly assess putative activity of ethanol at OCT3, we used HEK293 cells stably expressing hOCT3 [75], examined ethanol ’ s inhibition of [ 3 H]MPP + uptake into these cells, and obtained a Ki = 4.2 ± 0.2 mM (Fig.”
MethodInfluentialSelf-citationBennett, M. R., Farnell, L., Gibson, W. G. R., & Blair, D. H. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2003.09.014 · Cited by 10
Zwart, R., Verhaagh, S., de Jong, J., Lyon, M., & Barlow, D. (2001) · Mammalian Genome · doi:10.1007/s00335-001-3016-8 · Cited by 10
Chen, Z.-P., Wang, G., Huang, Q., Sun, Z.-F., Zhou, L.-Y., Wang, A.-D., & Panasci, L. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006245724456 · Cited by 10
Xiu, F.-R., Rausch, M., Gai, Z.-B., Su, S., Wang, S.-J., & Visentin, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032101 · Cited by 9
“OCT3 has been identified and characterized as a high-capacity, low-affinity transporter of monoamines, thus, initially named extraneuronal monoamine transporter (EMT) [100].”
BackgroundWan, S., Pan, Q., Yang, G., Kuang, J., & Luo, S.-Q. (2020) · Oncology Letters · doi:10.3892/ol.2020.11874 · Cited by 9
“SLC22A3 belongs to the amphiphilic solute facilitator family of integrated transmembrane proteins and has been found to be involved in the pharmacokinetics of catecholamine (42); and it was found that loss of SLC22A3 leads to increased proliferation and hepatocarcinogenesis of mice liver tumors induced by stilbene nit…”
BackgroundSTOCKER, S. L., Riedmaier, A. E., Schwab, M. G., & Giacomini, K. M. (2013) · Wiley eBooks · doi:10.1002/9781118353240.ch8 · Cited by 8
Bottalico, B., Noskova, V., Pilka, R., Larsson, I., Domanski, H., Casslén, B., & Hansson, S. R. (2007) · Molecular Reproduction and Development · doi:10.1002/mrd.20697 · Cited by 9
“Another family of plasmamembrane transporters, the organic cation transporters (OCT), known since many years to be responsible for the so-called type 2 uptake of monoamines (Iversen, 1965), and were recently cloned (Gorboulev et al., 1997;Koehler et al., 1997; Zhang et al., 1997; Grundemann et al., 1998).”
BackgroundMethodDrug uptake systems in liver and kidney.
van Montfoort, J. V., Hagenbuch, B., Groothuis, G. M., Koepsell, H., Meier, P. J., & Meijer, D. (2003) · Current drug metabolism · doi:10.2174/1389200033489460 · Cited by 9
Organic cation transporters in psychiatric and substance use disorders
Honan, L. E., Fraser‐Spears, R., & Daws, L. C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108574 · Cited by 9
Expression and clinical significance of organic cation transporter family in glioblastoma multiforme
Lian, Q., Xiao, S., Wang, Y., Wang, H., & Xie, D. (2021) · Irish Journal of Medical Science · doi:10.1007/s11845-021-02675-3 · Cited by 8
Acute stress reduces the emotional attentional blink: Evidence from human electrophysiology
Kan, Y., Wang, X., Chen, X., Zhao, H., Lan, J., & Duan, H. (2020) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-020-00847-9 · Cited by 13
Nomura, S., Tricoire, L., Cohen, I., Kuhn, B., Lambolez, B., & Hepp, R. (2020) · iScience · doi:10.1016/j.isci.2020.101710 · Cited by 8
“Cortical NA Transmission Is Critically Controlled by Catecholamine Reuptake The clearance of released catecholamines involves their recapture into catecholaminergic axons or neighboring cells by various transporters showing low selectivity for NA versus DA (Grundemann et al., 1998; Torres et al., 2003).”
BackgroundNeurophysiology of threat processing bias in combat‐related post‐traumatic stress disorder
DeLaRosa, B., Spence, J. S., Didehbani, N., Tillman, G. D., Motes, M. A., Bass, C., Kraut, M. A., & Hart, J. (2019) · Human Brain Mapping · doi:10.1002/hbm.24800 · Cited by 9
Solanki, R. R., Scholl, J., Watt, M., Renner, K., & Forster, G. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s40231 · Cited by 8
Norepinephrine uptake mechanisms in cardiovascular disease deserve our attention.
Schroeder, C., & Jordan, J. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31822eae22 · Cited by 8
“The organic cation transporter 3 (OCT3) was identified as the transporter mediating extraneuronal norepinephrine uptake.(1) Given the important effect of excess norepinephrine on cardiovascular regulation and disease progression, altered norepinephrine uptake could have important clinical implications.”
BackgroundHaenisch, B., Hiemke, C., & Bönisch, H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2281-9 · Cited by 8
Impact of culture media glucose levels on the intestinal uptake of organic cations
Faria, A., Monteiro, R., Pestana, D., Martel, F., de Freitas, V. D., Mateus, N., & Calhau, C. (2010) · Cytotechnology (Dordrecht) · doi:10.1007/s10616-010-9257-1 · Cited by 8
“…al. 2007), there is a gap in the literature concerning the importance of the redox state on OCT1- or OCT3-mediated transport, although these transporters possess several amino acid residues in intra- and extracellular domains (Grundemann et al. 1998; Hayer et al. 1999) that are prone to oxidation.”
Ribeiro, L., Martel, F., & Azevedo, I. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.06.002 · Cited by 8
Hayer, M., Bönisch, H., & Brüß, M. (1999) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2000.6430267.x · Cited by 8
Introduction to the Cellular Transport of Organic Cations
Ciarimboli, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-23793-0_1 · Cited by 8
Biology of ocular transporters: efflux and influx transporters in the eye
Dhananjay, P., Krishna, V., Dutt, V. A., & Mitra, A. (2013) · Elsevier eBooks · doi:10.1533/9781908818317.37 · Cited by 8
Rapid Corticosteroid Actions on Behavior: Mechanisms and Implications
Gasser, P. J., Lowry, C. A., & Orchinik, M. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00041-3 · Cited by 5
Weber, B. L., Beaver, J. N., & Gilman, T. L. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13810 · Cited by 6
Organic Cation Transporters and Nongenomic Glucocorticoid Action.
Benton, K. C., Lowry, C., & Gasser, P. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_493 · Cited by 7
Herráez, E., Al-Abdulla, R., Soto, M., Briz, O., Bettinger, D., Bantel, H., del Carmen, S., Serrano, M., Geier, A., Marín, J., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115812 · Cited by 6
“Several genetic variants have been identified in the latter, which have been associated with dysfunctional changes in this transporter [14].”
Extending the family: Roles for uptake2 transporters in regulation of monoaminergic signaling.
Gasser, P., & Daws, L. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.07.009 · Cited by 6
Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter.
Martel, F., Keating, E., & Azevedo, I. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01055-x · Cited by 6
Lai, Y.-R. (2013) · Elsevier eBooks · doi:10.1533/9781908818287.455 · Cited by 6
Chen, Z.-P., Pan, J., Huang, Q., Sun, Z.-F., Zhou, L.-Y., & Wang, A.-D. (2004) · Journal of Neuro-Oncology · doi:10.1023/a:1006480818373 · Cited by 6
MOLECULAR BACKGROUNDS OF INDIVIDUALISED PHARMACOTHERAPY
Neamțu, M. (2020) · FARMACIA · doi:10.31925/farmacia.2020.3.4 · Cited by 5
“transporter is likely to take over the excess of monoamine transmitters that have escaped the neuronal re-uptake, thus avoiding the uncontrolled spread of signals [20].”
BackgroundRusu, S., Lankelma, J., Jackson, J., van Mourik-Donga, L. A., Joëls, M., & Pennartz, C. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000370 · Cited by 5
“In addition, systemic CORT administration has been proposed to increase noradrenaline levels by blocking reuptake (Grundemann et al., 1998).”
Background[The neurotoxicity of pyridinium metabolites of haloperidol].
Górska, A., Marszałł, M., & Sloderbach, A. (2015) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1175009 · Cited by 5
“Wykazano, że ma zdolność nie tylko transportowania kationów HPP+, RHPP+, ale także neuroprzekaźników do OUN [13,43].”
McKenzie, A. I., Mahmassani, Z. S., Petrocelli, J. J., de Hart, N. M. M. P., Fix, D. K., Ferrara, P. J., LaStayo, P. C., Marcus, R. L., Rondina, M. T., Summers, S. A., et al. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111804 · Cited by 18
Quinine enhances the behavioral stimulant effect of cocaine in mice
Huertas, A., Wessinger, W. D., Kucheryavykh, Y. V., Sanabria, P., Eaton, M. J., Skatchkov, S. N., Rojas, L. V., Maldonado-Martínez, G., & Inyushin, M. Y. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.021 · Cited by 3
“Recently, low-affinity high-capacity monoamine transporters belonging to organic cation transporters family (OCT), or extracellular monoamine transporter (EMT) were characterized (Gründemann et al., 1998).”
Hansson, S. R., Bottalico, B., Amer‐Wåhlin, I., Maršál, K., & Ley, D. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00262.x · Cited by 3
Maekawa, M., Murayama, T., & Nomura, Y. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00097-8 · Cited by 4
Organic Anion and Cation Transporters in Renal Elimination of Drugs
Burckhardt, G., & Koepsell, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00072-0 · Cited by 5
Metadata
- Authors
- Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E.
- Affiliations
- Heidelberg University (DE)
- Corresponding author
- Gründemann, Dirk
- Venue
- Nature Neuroscience
- Published
- 1998-09
- Volume
- 1
- Issue
- 5
- Pages
- 349-351
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- DOI
- 10.1038/1557
- OpenAlex
- W1493374490
- Cited by
- 374
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 11 · 2018: 9 · 2017: 8 · 2016: 16 · 2015: 13 · 2014: 17 · 2013: 25 · 2012: 13
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- sympathetic innervation, pharmacological characterization
- MeSH terms
- Organic Cation Transporter 3, Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 6, Corticosterone, Humans, Kinetics, Molecular Sequence Data, Myocardium, Norepinephrine, 1-Methyl-4-phenylpyridinium, Organic Cation Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review